Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1046434

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1046434

Global Vascular Closure Device Market Size, Share & Trends Analysis Report By Type, By Access, By Procedure, Regional Outlook, Competitive Strategies and Segment Forecast - 2030

PUBLISHED:
PAGES: 206 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

Global vascular closure device market is projected to worth USD 1.58 Bn by 2030.

According to SPER Market Research, the global vascular closure device market was valued at USD 1.12 Bn in 2021 and estimated to reach USD 1.58 Bn by 2030 with a CAGR of 7.4%. The global burden of cardiovascular disorders causes around 17 Mn deaths per year across the globe. The number of patients with cardiovascular disorder will continue to grow as the geriatric population will increase in coming years.

Impact of COVID-19 on the Vascular Closure Device Market

The upsurge in COVID-19 infections across the world redirect the resources and professionals towards COVID relief thus, compromising with wound care services, and elective surgeries. The temporary denial is notified for all the non-emergent healthcare services. Enforcing of lockdowns, curfews and fear of getting infected restrict the patients to visit hospitals, clinics or OPDs.

Scope of Report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered

By Type, By Access, By Procedure.

Geographies covered

North America, Europe, APAC, Latin America, and the Middle East & Africa.

Companies Covered: Abbott, Cardinal Health, Medtronic, TZ Medical, Merit Medical Systems, Inc., Rex Medical, Vygon Company, Vasorum Ltd., Terumo Corporation, Cardiva Medical, Inc., Boston Scientific Corporation, Scion BioMedical, Morris Innovative, Inc., Vivasure Medical Ltd., Teleflex Incorporated, Tricol Biomedical, Transluminal Technologies, Meril Life Sciences Pvt. Ltd., Medas USA, Advanced Vascular Dynamics, Marine Polymer Technologies, Inc.

Driver: Rising prevalence of cardiovascular diseases

High occurrence of cardiovascular diseases across the world will render high growth of vascular closure devices market in the forecast period. Rising prevalence of obesity, increasing geriatric population is leading to higher number of patients suffering from cardiovascular diseases.

Challenge: High medical costs and risk associated with vascular closure devices

The high costs of vascular closure devices can hinder the growth of this market. Countries with poor reimbursement policies can pose significant challenge for the adaption of vascular closure devices. The risks associated with the use of vascular closure devices during surgical procedures such as infections, bleeding, device failures and thrombotic events can also restrict the estimated growth.

Opportunity: Rising demand for minimally invasive procedures

The vascular closure devices provide minimal invasion and reduces risk of excessive blood loss during the surgeries. The rising awareness of patients towards minimally invasive procedures will provide growth opportunities for this market. Rising number of hospitals and healthcare funding will also support the growth of vascular closure devices.

Vascular Closure Devices Market by Product type:

Based on product type, the market has been segmented into passive approximators, active approximators and external Hemostatic Devices.

Vascular Closure Devices Market by Access:

Based on access, the market has been segmented into femoral access and radial access.

Vascular Closure Devices Market by Procedures:

Based on procedures, the market has been segmented into interventional cardiology and interventional radiology/vascular surgery.

Vascular Closure Devices Market by Region:

North America accounted for the largest share of Vascular Closure devices market. The large share is ascribed by sophisticated infrastructure, increasing prevalence of cardiovascular diseases and presence of leading players of this market in this region.

Product Code: MEDE2202

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. COVID-19 Impact of the Vascular Closure Device Market
  • 4.4. Market Trends

5. Global Vascular Closure Device Market, By Type, 2021-2030 (USD Million)

  • 5.1. Passive Approximators
    • 5.1.1. Cotton plugs
    • 5.1.2. Sealant or gel-based devices
    • 5.1.3. Compression assists devices
  • 5.2. Active Approximators
    • 5.2.1. Suture-based devices
    • 5.2.2. Clip-based devices
  • 5.3. External Hemostatic Devices

6. Global Vascular Closure Devices Market, By Access, 2021-2030 (USD Million)

  • 6.1. Femoral Access
  • 6.2. Radial Access

7. Global Vascular Closure Devices Market, By Procedures, 2021-2030 (USD Million)

  • 7.1. Interventional Cardiology
  • 7.2. Interventional Radiology/Vascular Surgery

8. Global Vascular Closure Devices Market, By Geography, 2021-2030 (USD Million)

  • 8.1. North America
    • 8.1.1. US
    • 8.1.2. Canada
  • 8.2. Europe
    • 8.2.1. Germany
    • 8.2.2. UK
    • 8.2.3. France
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Rest of Europe
  • 8.3. Asia-Pacific
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. Rest of Asia-Pacific
  • 8.4. Rest of the World
    • 8.4.1. Latin America
    • 8.4.2. Middle East & Africa

9. Competitive Landscape

  • 9.1. Introduction
  • 9.2. Market Share Analysis, By Key Players (2021)
  • 9.3. Competitive Scenario
    • 9.3.1. Product Launches
    • 9.3.2. Partnerships, Collaborations and Agreements
    • 9.3.3. Acquisitions
    • 9.3.4. Expansions
    • 9.3.5. Other Developments

10. Company Profiles

  • 10.1. Abbott, Cardinal Health
  • 10.2. Advanced Vascular Dynamics
  • 10.3. Boston Scientific Corporation
  • 10.4. Cardiva Medical, Inc.
  • 10.5. Marine Polymer Technologies, Inc.
  • 10.6. Medas USA
  • 10.7. Medtronic
  • 10.8. Meril Life Sciences Pvt. Ltd.
  • 10.9. Merit Medical Systems, Inc.
  • 10.10. Morris Innovative, Inc.
  • 10.11. Rex Medical
  • 10.12. Scion BioMedical
  • 10.13. Teleflex Incorporated
  • 10.14. Terumo Corporation
  • 10.15. Transluminal Technologies
  • 10.16. Tricol Biomedical
  • 10.17. TZ Medical
  • 10.18. Vasorum Ltd.
  • 10.19. Vivasure Medical Ltd.
  • 10.20. Vygon Company

11. Appendix

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!